Savara (SVRA) financial statements

Healthcare · Biotechnology · Market cap $922M

Net income was -$119M.

Free cash flow was -$101M.

The diluted share count rose 11243% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.1-0.1-0.100.12016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Savara's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$400,000$0—$0$257,000—————
Research and development$8M$19M$37M$39M$35M$29M$28M$44M$78M$81M
Selling, general and admin$9M$11M$11M$13M$14M$12M$11M$16M$25M$42M
Operating income-$11M-$30M-$70M-$79M-$49M-$41M-$39M-$60M-$103M-$124M
Interest expense$452,000$1M————————
Pre-tax income-$11M-$33M-$69M-$78M-$50M-$43M-$38M-$55M-$96M-$119M
Income tax-$357,000-$4M-$7M—————$9,000$0
Net income-$11M-$30M-$62M-$78M-$50M-$43M-$38M-$55M-$96M-$119M
EPS (diluted)-$5.62-$1.76-$1.85-$1.95-$0.84-$0.32-$0.25-$0.33-$0.48-$0.53
Diluted shares2M18M33M40M59M134M153M165M198M222M
Operating margin-2737.0%———-19182.9%—————
Net margin-2730.8%———-19305.4%—————

Balance sheet

Fiscal years, from Savara's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$11M$94M$111M$122M$82M$161M$126M$162M$196M$236M
Total current assets$15M$98M$113M$124M$85M$165M$129M$166M$202M$242M
Property, plant and equipment$793,000$925,000$522,000$352,000$156,000$73,000$51,000$270,000$165,000$100,000
Goodwill$3M$27M$27M—$0—————
Total assets$29M$160M$152M$136M$98M$177M$140M$178M$213M$253M
Total current liabilities$3M$6M$7M$11M$8M$15M$6M$11M$15M$20M
Long-term debt————$25M$17M$26M$26M$27M$30M
Total liabilities$21M$40M$44M$35M$33M$32M$32M$37M$41M$50M
Shareholders' equity-$36M$119M$108M$102M$64M$144M$108M$140M$171M$203M
Net debt-$13M-$22M-$24M-$50M$2M-$8M-$26M-$237,000$11M-$3M

Cash flow

Fiscal years, from Savara's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$8M-$28M-$39M-$45M-$40M-$40M-$35M-$51M-$89M-$101M
Capital spending$8,000$495,000$141,000$148,000$47,000$57,000$9,000$296,000$25,000$22,000
Free cash flow-$8M-$29M-$39M-$45M-$40M-$40M-$35M-$51M-$89M-$101M
Stock-based compensation$209,000$552,000$4M$4M$5M$3M$2M$4M$10M$14M
Net borrowing—-$4M——-$514,000—$88,000——$2M
Free cash flow margin-2094.5%———-15518.7%—————
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for SVRA.
Open SVRA in Investingly

Questions

How much free cash flow does Savara generate?

-$101M in fiscal 2025 (operating cash flow minus capital spending).

From Savara's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.